News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Gould Gregory A
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/21/2022 |
4
| Gould Gregory A (CFO) has filed a Form 4 on Charlotte's Web Holdings, Inc.
Txns:
| Granted 1,200,000 options to buy
@ $0.44, valued at
$528k
|
|
07/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/11/2020 |
4
| Gould Gregory A (CFO) has filed a Form 4 on NewAge, Inc.
Txns:
| Paid exercise price by delivering 9,564 shares
@ $3.16, valued at
$30.2k
|
|
10/26/2020 |
4
| Gould Gregory A (CFO) has filed a Form 4 on NewAge, Inc.
Txns:
| Paid exercise price by delivering 9,564 shares
@ $2.72, valued at
$26k
|
|
12/12/2019 |
4
| Gould Gregory A (CFO) has filed a Form 4 on New Age Beverages Corp
Txns:
| Granted 100,000 shares
@ $0 Granted 100,000 options to buy
@ $1.83, valued at
$183k
|
|
07/03/2019 |
4
| Gould Gregory A (CFO) has filed a Form 4 on New Age Beverages Corp
Txns:
| Granted 100,000 shares
@ $0 Granted 250,000 shares
@ $0 Granted 100,000 options to buy
@ $4.75, valued at
$475k
|
|
06/19/2019 |
4
| Gould Gregory A (Director) has filed a Form 4 on CytoDyn Inc.
Txns:
| Granted 100,000 options to buy
@ $0.52, valued at
$52k
|
|
11/19/2018 |
4
| Gould Gregory A (Director) has filed a Form 4 on CytoDyn Inc.
Txns:
| Granted 19,176 shares
@ $0 Granted 50,000 options to buy
@ $0.66, valued at
$33k
Granted 50,000 options to buy
@ $2, valued at
$100k
Granted 25,000 options to buy
@ $1.55, valued at
$38.8k
Granted 50,000 options to buy
@ $0.975, valued at
$48.8k
Granted 50,000 options to buy
@ $1.09, valued at
$54.5k
Granted 100,000 options to buy
@ $0.68, valued at
$68k
Granted 75,000 options to buy
@ $0.57, valued at
$42.8k
Granted 160,662 options to buy
@ $0.56, valued at
$90k
Granted 50,000 options to buy
@ $0.8, valued at
$40k
Granted 100,000 options to buy
@ $0.49, valued at
$49k
|
|
11/16/2018 |
4
| Gould Gregory A (Director) has filed a Form 4 on CytoDyn Inc.
Txns:
| Disposed/sold 19,176 shares
@ $0 Disposed/sold 50,000 options to buy
@ $0.66, valued at
$33k
Disposed/sold 50,000 options to buy
@ $2, valued at
$100k
Disposed/sold 25,000 options to buy
@ $1.55, valued at
$38.8k
Disposed/sold 50,000 options to buy
@ $0.975, valued at
$48.8k
Disposed/sold 50,000 options to buy
@ $1.09, valued at
$54.5k
Disposed/sold 100,000 options to buy
@ $0.68, valued at
$68k
Disposed/sold 75,000 options to buy
@ $0.57, valued at
$42.8k
Disposed/sold 160,662 options to buy
@ $0.56, valued at
$90k
Disposed/sold 50,000 options to buy
@ $0.8, valued at
$40k
Disposed/sold 100,000 options to buy
@ $0.49, valued at
$49k
|
|
06/12/2018 |
4
| Gould Gregory A (Director) has filed a Form 4 on CytoDyn Inc.
Txns:
| Granted 100,000 options to buy
@ $0.49, valued at
$49k
|
|
02/16/2018 |
4
| Gould Gregory A (Director) has filed a Form 4 on CytoDyn Inc.
Txns:
| Disposed/sold 50,000 options to buy
@ $0.8, valued at
$40k
Granted 50,000 options to buy
@ $0.8, valued at
$40k
|
|
02/09/2018 |
4
| Gould Gregory A (Director) has filed a Form 4 on CytoDyn Inc.
Txns:
| Granted 160,662 options to buy
@ $0.56, valued at
$90k
|
|
06/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/11/2016 |
4
| Gould Gregory A (CFO) has filed a Form 4 on AYTU BIOSCIENCE, INC
Txns:
| Granted 165,000 shares
@ $0 Disposed/sold 20,834 options to buy
@ $18.12, valued at
$377.5k
Granted 20,834 options to buy
@ $3.23, valued at
$67.3k
Granted 25,000 options to buy
@ $3.23, valued at
$80.8k
|
|
06/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/23/2015 |
4
| Gould Gregory A (Director) has filed a Form 4 on CYTODYN INC
Txns:
| Disposed/sold 50,000 options to buy
@ $2, valued at
$100k
Granted 50,000 options to buy
@ $2, valued at
$100k
Disposed/sold 25,000 options to buy
@ $1.55, valued at
$38.8k
Granted 25,000 options to buy
@ $1.55, valued at
$38.8k
Disposed/sold 50,000 options to buy
@ $0.975, valued at
$48.8k
Granted 50,000 options to buy
@ $0.975, valued at
$48.8k
|
|
11/13/2015 |
4
| Gould Gregory A (CFO) has filed a Form 4 on AYTU BIOSCIENCE, INC
Txns:
| Granted 250,000 options to buy
@ $1.51, valued at
$377.5k
|
|
08/03/2015 |
4
| Gould Gregory A (CFO) has filed a Form 4 on Ampio Pharmaceuticals, Inc.
Txns:
| Granted 100,000 options to buy
@ $2.6, valued at
$260k
|
|
06/02/2015 |
4
| Gould Gregory A (Director) has filed a Form 4 on CYTODYN INC
Txns:
| Granted 50,000 options to buy
@ $0.975, valued at
$48.8k
|
|
06/02/2014 |
4
| Gould Gregory A (Director) has filed a Form 4 on CYTODYN INC
Txns:
| Granted 50,000 options to buy
@ $0.66, valued at
$33k
|
|
06/03/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/04/2013 |
4
| Gould Gregory A (Director) has filed a Form 4 on CYTODYN INC
Txns:
| Granted 2,500 shares
@ $0 |
|
12/04/2012 |
4
| Gould Gregory A (Director) has filed a Form 4 on CYTODYN INC
Txns:
| Granted 1,562 shares
@ $0 |
|
09/05/2012 |
4
| GOULD GREGORY A (Director) has filed a Form 4 on CYTODYN INC
Txns:
| Granted 3,246 shares
@ $0 |
|
06/04/2012 |
4
| GOULD GREGORY A (Director) has filed a Form 4 on CYTODYN INC
Txns:
| Granted 25,000 options to buy
@ $1.55, valued at
$38.8k
|
|
05/23/2012 |
4
| GOULD GREGORY A (Director) has filed a Form 4 on CYTODYN INC
Txns:
| Granted 3,743 shares
@ $0 |
|
03/09/2012 |
4
| GOULD GREGORY A (Interim CEO, CFO, Treas & Sec.) has filed a Form 4 on SERACARE LIFE SCIENCES INC
Txns:
| Paid exercise price by delivering 1,119 shares
@ $3.97, valued at
$4.4k
|
|
|
|
|